Safety and efficacy of faldaprevir with pegylated interferon alfa-2a and ribavirin in Japanese patients with chronic genotype-1 hepatitis C infection-Reference-Cited by-同舟云学术

Safety and efficacy of faldaprevir with pegylated interferon alfa-2a and ribavirin in Japanese patients with chronic genotype-1 hepatitis C infection

Published:2013-08-15 Issue:1 Volume:34 Page:78-88
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Nishiguchi Shuhei¹,Sakai Yoshiyuki¹,Kuboki Makoto²,Tsunematsu Satoshi³,Urano Yasuhisa⁴,Sakamoto Wataru⁵,Tsuda Yasuhiro⁶,Steinmann Gerhard⁷,Omata Masao⁸⁹

Affiliation:

1. Division of Hepatobiliary and Pancreatic Disease; Hyogo College of Medicine; Nishinomiya Japan

2. Liver Disease Treatment Center; Kurashiki Medical Center; Kurashiki Japan

3. The Center for Liver Diseases; Department of Internal Medicine; Kitasato Institute Hospital; Tokyo Japan

4. Clinical Research Department; Nippon Boehringer Ingelheim Co., Ltd.; Tokyo Japan

5. Medical Data Services Department; Nippon Boehringer Ingelheim Co., Ltd.; Kobe Pharma Research Institute; Kobe Japan

6. Clinical PK/PD Group; Nippon Boehringer Ingelheim Co.; Japan

7. Clinical Operations; Boehringer Ingelheim Pharma GmbH & Co. KG; Biberach Germany

8. Executive Head of Hospital; Yamanashi Prefectural Central Hospital; Kofu Japan

9. Department of Gastroenterology; Graduate School of Medicine; University of Tokyo; Tokyo Japan

Funder

Boehringer Ingelheim

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12254/fullpdf

Reference29 articles.

1. World Health Organization Hepatitis C Fact sheet N°164 2012 http://www.who.int/mediacentre/factsheets/fs164/en/index.html

2. The global health burden of hepatitis C virus infection;Negro;Liver Int,2011

3. The burden of illness for patients with viral hepatitis C: evidence from a national survey in Japan;Liu;Value Health,2012

4. All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population;El-Kamary;Clin Infect Dis,2011

5. Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006;Walter;J Hepatol,2011

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct-acting antivirals for chronic hepatitis C;Cochrane Database of Systematic Reviews;2017-09-18

2. Population pharmacokinetics of peginterferon α2a in patients with chronic hepatitis B;Scientific Reports;2017-08-11

3. Direct-acting antivirals for chronic hepatitis C;Cochrane Database of Systematic Reviews;2017-06-06

4. Safety and efficacy of faldaprevir in combination with pegylated interferon α-2b and ribavirin in Japanese patients with genotype-1 chronic hepatitis C virus infection;Hepatology Research;2016-08-10

5. Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials;Annals of Hepatology;2016-05